Search

everythinglearnresearchcommunity

for

Search:↓

A document listed serious side effects from various drugs, including deaths and diseases, emphasizing the importance of being aware of drug side effects.

Nanoparticles can speed up wound healing and deliver drugs effectively but may have potential toxicity risks.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

A new method was developed to accurately detect and measure 47 different drug ingredients in various products.

Cosmeceuticals are popular for their skin health benefits and anti-aging effects.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Finding functions for unknown GPCRs is hard but key for making new drugs.

A rare lupus case on the chin was successfully treated with steroids and immunomodulators after accurate diagnosis using advanced imaging techniques.

Sertraline can cause hair loss, which stops after stopping the drug.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Children with scalp fungal infections need proper diagnosis and treatment, usually with antifungal medications, and newer drugs may offer quicker recovery.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

Hydrogels have great potential for improving wound care, drug delivery, and tissue engineering in veterinary medicine.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Silver nanoparticles are useful in medicine and technology for their antibacterial properties and potential in drug delivery and dentistry.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Early diagnosis, stopping the suspected drug, and supportive care are crucial for treating Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.